For Pharma

IPH offers raw, de-identified, GxP-compliant data for pipeline research that integrates seamlessly with existing EHR systems and is collected from a proprietary network of specialty healthcare providers.

By creating digital assessments that integrate population health data, objective measurements, patient-reported outcomes, and clinical observations, IPH provides invaluable data for evaluating the efficacy of therapies at both the patient and population level.

IPH affords access to meaningful, real-world data for comparative efficacy research and supports analytics for novel and existing therapies. Pharmaceutical companies leveraging access to a spectrum of objective patient performance data across products in the same disease state can help improve the design of clinical trials and gain a competitive edge in therapy development.

From identifying unmet needs to demonstrating the efficacy and real world value of assets under development, IPH delivers unmatched data-driven insights that are both personalized and scalable to address your pipeline targets.

Learn More About How IPH’s Clinical Advisor Is Being Used by Our Clients

Access clinical data to inform disease trajectories, identify effective therapies, and target opportunities for preemptive intervention.

Gain unparalleled insight into the efficacy of therapies for your patients with objective digital assessments available at your fingertips.

Use raw, de-identified, GxP-compliant data to inform research priorities, chart trajectories of disease, and pinpoint unmet patient needs.